TENAYA THERAPEUTICS INC (TNYA) Fundamental Analysis & Valuation

NASDAQ:TNYA • US87990A1060

Current stock price

0.66 USD
-0.03 (-4.98%)
At close:
0.675 USD
+0.02 (+2.27%)
After Hours:

This TNYA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. TNYA Profitability Analysis

1.1 Basic Checks

  • In the past year TNYA has reported negative net income.
  • In the past year TNYA has reported a negative cash flow from operations.
  • In the past 5 years TNYA always reported negative net income.
  • In the past 5 years TNYA always reported negative operating cash flow.
TNYA Yearly Net Income VS EBIT VS OCF VS FCFTNYA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • TNYA's Return On Assets of -61.66% is on the low side compared to the rest of the industry. TNYA is outperformed by 60.54% of its industry peers.
  • The Return On Equity of TNYA (-73.50%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -61.66%
ROE -73.5%
ROIC N/A
ROA(3y)-75.7%
ROA(5y)-58.91%
ROE(3y)-94.06%
ROE(5y)-71.82%
ROIC(3y)N/A
ROIC(5y)N/A
TNYA Yearly ROA, ROE, ROICTNYA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • TNYA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNYA Yearly Profit, Operating, Gross MarginsTNYA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. TNYA Health Analysis

2.1 Basic Checks

  • TNYA has more shares outstanding than it did 1 year ago.
  • TNYA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for TNYA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TNYA Yearly Shares OutstandingTNYA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
TNYA Yearly Total Debt VS Total AssetsTNYA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TNYA has an Altman-Z score of -3.30. This is a bad value and indicates that TNYA is not financially healthy and even has some risk of bankruptcy.
  • TNYA has a Altman-Z score (-3.30) which is in line with its industry peers.
  • TNYA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.3
ROIC/WACCN/A
WACCN/A
TNYA Yearly LT Debt VS Equity VS FCFTNYA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • TNYA has a Current Ratio of 6.84. This indicates that TNYA is financially healthy and has no problem in meeting its short term obligations.
  • TNYA has a Current ratio of 6.84. This is in the better half of the industry: TNYA outperforms 65.76% of its industry peers.
  • A Quick Ratio of 6.84 indicates that TNYA has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 6.84, TNYA is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.84
Quick Ratio 6.84
TNYA Yearly Current Assets VS Current LiabilitesTNYA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. TNYA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 53.03% over the past year.
EPS 1Y (TTM)53.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • TNYA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.07% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24.05%
EPS Next 2Y46.28%
EPS Next 3Y72.51%
EPS Next 5Y64.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TNYA Yearly Revenue VS EstimatesTNYA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2029 2030 2031 2032 2033 2B 4B 6B
TNYA Yearly EPS VS EstimatesTNYA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. TNYA Valuation Analysis

4.1 Price/Earnings Ratio

  • TNYA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TNYA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNYA Price Earnings VS Forward Price EarningsTNYA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNYA Per share dataTNYA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

  • TNYA's earnings are expected to grow with 72.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.28%
EPS Next 3Y72.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TNYA Dividend Analysis

5.1 Amount

  • No dividends for TNYA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TNYA Fundamentals: All Metrics, Ratios and Statistics

TENAYA THERAPEUTICS INC

NASDAQ:TNYA (4/6/2026, 8:11:21 PM)

After market: 0.675 +0.02 (+2.27%)

0.66

-0.03 (-4.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-11
Earnings (Next)05-01
Inst Owners50.54%
Inst Owner Change0%
Ins Owners0.53%
Ins Owner Change14.06%
Market Cap143.22M
Revenue(TTM)N/A
Net Income(TTM)-90.60M
Analysts84.29
Price Target10.2 (1445.45%)
Short Float %11.72%
Short Ratio5.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.68%
Min EPS beat(2)2.97%
Max EPS beat(2)20.39%
EPS beat(4)3
Avg EPS beat(4)11.16%
Min EPS beat(4)-23.84%
Max EPS beat(4)45.1%
EPS beat(8)7
Avg EPS beat(8)12.3%
EPS beat(12)11
Avg EPS beat(12)13.81%
EPS beat(16)13
Avg EPS beat(16)9.83%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.11%
PT rev (3m)6.06%
EPS NQ rev (1m)31.21%
EPS NQ rev (3m)31.21%
EPS NY rev (1m)0%
EPS NY rev (3m)6.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)150%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -61.66%
ROE -73.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-75.7%
ROA(5y)-58.91%
ROE(3y)-94.06%
ROE(5y)-71.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.84
Quick Ratio 6.84
Altman-Z -3.3
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)11.23%
Cap/Depr(5y)240.24%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y24.05%
EPS Next 2Y46.28%
EPS Next 3Y72.51%
EPS Next 5Y64.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y20.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.36%
EBIT Next 3Y-21.8%
EBIT Next 5YN/A
FCF growth 1Y24.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.57%
OCF growth 3YN/A
OCF growth 5YN/A

TENAYA THERAPEUTICS INC / TNYA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TENAYA THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TNYA.


What is the valuation status of TENAYA THERAPEUTICS INC (TNYA) stock?

ChartMill assigns a valuation rating of 1 / 10 to TENAYA THERAPEUTICS INC (TNYA). This can be considered as Overvalued.


Can you provide the profitability details for TENAYA THERAPEUTICS INC?

TENAYA THERAPEUTICS INC (TNYA) has a profitability rating of 0 / 10.


How financially healthy is TENAYA THERAPEUTICS INC?

The financial health rating of TENAYA THERAPEUTICS INC (TNYA) is 7 / 10.